Site Map. Text Size. Search MU Research.
Office of Grant Writing & Publications.

Pediatric Early Phase Clinical Trials Network (UM1)

Limited Submission Announcement

PLEASE READ: Internal Procedures for Limited Submissions

Agency:

Department of Health and Human Services (HHS) | National Institutes of Health (NIH) | National Cancer Institute (NCI)

Web Address:

https://www.grants.gov/web/grants/view-opportunity.html?oppId=294514

Post Date:

07/11/17

Amount:

Up to $3,600,000

Campus Deadline:

7/31/2017

External Deadline(s):

September 14, 2017

Notes:

Only one application per institution is allowed.

The purpose of this Funding Opportunity Announcement (FOA) is to enhance NCI's program for conducting early phase clinical trials in children with cancer, currently supported as the Children's Oncology Group (COG) Phase 1 & Pilot Consortium. The overall goal is to ensure that high priority novel agents can be tested in pediatric patients in a timely manner. Towards this end, the clinical research activities now supported through the COG Phase 1 & Pilot Consortium will be continued (and enhanced) by the Pediatric Early Phase Clinical Trials Network (PEP-CTN).
 

 

All limited submission announcements can be tracked by deadline via the Calendar at research.missouri.edu or by announcement date via the Limited Submissions listing at http://research.missouri.edu/lsas/.